160 related articles for article (PubMed ID: 35403131)
1. Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for Brachytherapy.
Facondo G; Vullo G; DE Sanctis V; Valeriani M; Ascolese AM; Massaro M; Anzellini D; Osti MF
Cancer Diagn Progn; 2021; 1(2):53-60. PubMed ID: 35403131
[TBL] [Abstract][Full Text] [Related]
2. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA
Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626
[TBL] [Abstract][Full Text] [Related]
3. MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience.
Hadi I; Eze C; Schönecker S; von Bestenbostel R; Rogowski P; Nierer L; Bodensohn R; Reiner M; Landry G; Belka C; Niyazi M; Corradini S
Radiat Oncol; 2022 Jan; 17(1):8. PubMed ID: 35033132
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive stereotactic ablative boost in patients with locally advanced cervical cancer.
Dalwadi S; Echeverria A; Jhaveri P; Bui T; Waheed N; Tran D; Bonnen M; Ludwig M
Int J Gynecol Cancer; 2020 Nov; 30(11):1684-1688. PubMed ID: 32636273
[TBL] [Abstract][Full Text] [Related]
5. CyberKnife Boost for Patients with Cervical Cancer Unable to Undergo Brachytherapy.
Haas JA; Witten MR; Clancey O; Episcopia K; Accordino D; Chalas E
Front Oncol; 2012; 2():25. PubMed ID: 22655266
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy.
Ito K; Nakajima Y; Ogawa H; Furusawa A; Murofushi KN; Kito S; Kino N; Yasugi T; Uno T; Karasawa K
Jpn J Radiol; 2024 Apr; ():. PubMed ID: 38625476
[TBL] [Abstract][Full Text] [Related]
7. Determining the recommended dose of stereotactic body radiotherapy boost in patients with cervical cancer who are unsuitable for intracavitary brachytherapy: a phase I dose-escalation study.
Ito K; Kito S; Nakajima Y; Shimizuguchi T; Ogawa H; Nihei K; Tanaka H; Kino N; Yasugi T; Karasawa K
Jpn J Clin Oncol; 2019 Sep; 49(9):856-861. PubMed ID: 31112278
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of robotic radiosurgery for non brachytherapy patients with cervical cancer.
Morgenthaler J; Köhler C; Budach V; Sehouli J; Stromberger C; Besserer A; Trommer M; Baues C; Marnitz S
Strahlenther Onkol; 2021 Jun; 197(6):474-486. PubMed ID: 32970164
[TBL] [Abstract][Full Text] [Related]
9. Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost.
Phuong C; Chan JW; Ni L; Wall P; Mohamad O; Wong AC; Hsu IC; Chang AJ
Radiat Oncol; 2022 Jan; 17(1):12. PubMed ID: 35057827
[TBL] [Abstract][Full Text] [Related]
10. Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer.
Gorovets D; Hopkins M; Kollmeier M; Moore A; Goel A; Shasha D; Brennan V; McBride S; Cohen G; Damato AL; Zelefsky MJ
Brachytherapy; 2021; 20(6):1099-1106. PubMed ID: 34588146
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy boost in patients with cervical cancer.
Gultekin M; Yilmaz MT; Yuce Sari S; Yildiz D; Ozyigit G; Yildiz F
J Obstet Gynaecol; 2022 Oct; 42(7):3033-3040. PubMed ID: 35653802
[TBL] [Abstract][Full Text] [Related]
12. Why brachytherapy boost is the treatment of choice for most women with locally advanced cervical carcinoma?
Al Feghali KA; Elshaikh MA
Brachytherapy; 2016; 15(2):191-9. PubMed ID: 26810408
[TBL] [Abstract][Full Text] [Related]
13. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
14. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response.
Jabbari S; Weinberg VK; Kaprealian T; Hsu IC; Ma L; Chuang C; Descovich M; Shiao S; Shinohara K; Roach M; Gottschalk AR
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):228-34. PubMed ID: 21183287
[TBL] [Abstract][Full Text] [Related]
16. Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa).
Peyraga G; Lizee T; Khalifa J; Blais E; Mauriange-Turpin G; Supiot S; Krhili S; Tremolieres P; Graff-Cailleaud P
Cancer Radiother; 2021 Jun; 25(4):400-409. PubMed ID: 33478838
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
Ito K; Shimizuguchi T; Karasawa K
Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
[TBL] [Abstract][Full Text] [Related]
18. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
[TBL] [Abstract][Full Text] [Related]
19. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer.
Cihoric N; Tsikkinis A; Tapia C; Aebersold DM; Zlobec I; Lössl K
Radiat Oncol; 2015 Nov; 10():240. PubMed ID: 26597282
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal.
Bertin E; Benezery K; Kee DLC; François E; Evesque L; Gautier M; Gerard JP; Hannoun-Levi JM; Falk AT
J Contemp Brachytherapy; 2018 Dec; 10(6):522-531. PubMed ID: 30662475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
